Special Issue "Vascular Biology and Therapeutics"
Deadline for manuscript submissions: closed (31 August 2016).
Prof. Dr. Shaker A. Mousa
The Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, 1 Discovery Drive (Room 238), Rensselaer, NY 12144, USA
Website | E-Mail
Fax: +1 518-694 7567
Interests: pharmaceuticals, biopharmaceuticals, and diagnostics; nanomedicine; cardiovascular diseases; neurological disorders; hematology and oncology; biosimilar and nanosimilar; angiogenesis, inflammation, thrombosis, integrin, and cell adhesion molecules; target identification, molecular mechanisms, and signaling pathways; preclinical, clinical, marketing, and post-marketing studies; regulatory and ethical issues
The theme of this timely Vascular Biology and Therapeutics Special Issue will highlight exciting discoveries in vascular biology that would enhance the diagnosis and treatment of cardiovascular and vascular disorders. This series would provide insights into the interface between inflammation, angiogenesis, and thrombosis in impacting vascular disorders, including atherosclerosis and atherothrombosis, via the alteration in blood flow and organ perfusion (ischemia/reperfusion injury). This Special Issue will focus on mechanisms that regulate inflammation, thrombosis, and angiogenesis that impact various vascular disorders, such as cardiovascular, cerebrovascular, and peripheral vascular diseases. Additionally, recent advances in the management of various vascular disorders, such as novel anti-dyslipidemia, antithrombotic, anti-angiogenesis, and anti-inflammatory treatments, will be highlighted.
Prof. Dr. Shaker A. Mousa
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- vascular biology
- vascular therapeutics
- vascular disorders (cerebrovascular, cardiovascular, peripheral vascular disorders).
- angiogenesis modulation
- inflammatory modulators
- novel oral anticoagulants
- oral antiplatelet
- anti-adhesion molecules